
浏览全部资源
扫码关注微信
1.400042 重庆,陆军军医大学(第三军医大学)第三附属医院野战外科研究所心血管内科,重庆市心血管病研究所
2.400042 重庆,陆军军医大学(第三军医大学)第三附属医院野战外科研究所重症医学科
3.735018 甘肃酒泉,95877部队医院内科
[彭晓玉, E-mail:pengxiaoyu543@sina.com PENG Xiaoyu, E-mail: pengxiaoyu543@sina.com
收稿:2018-07-01,
修回:2018-09-21,
纸质出版:2018-12-30
移动端阅览
蔡越, 罗浩, 彭晓玉. TSPO调控肾脏血管紧张素Ⅱ1型受体表达促进原发性高血压大鼠血压升高[J]. 第三军医大学学报, 2018,40(24):2222-2228.
Yue CAI, Hao LUO, Xiaoyu PENG. Translocator protein promotes renal angiotensin Ⅱ type 1 receptor expression and increases blood pressure in spontaneously hypertensive rats[J]. Journal of Third Military Medical University, 2018, 40(24): 2222-2228.
蔡越, 罗浩, 彭晓玉. TSPO调控肾脏血管紧张素Ⅱ1型受体表达促进原发性高血压大鼠血压升高[J]. 第三军医大学学报, 2018,40(24):2222-2228. DOI: 10.16016/j.1000-5404.201807001.
Yue CAI, Hao LUO, Xiaoyu PENG. Translocator protein promotes renal angiotensin Ⅱ type 1 receptor expression and increases blood pressure in spontaneously hypertensive rats[J]. Journal of Third Military Medical University, 2018, 40(24): 2222-2228. DOI: 10.16016/j.1000-5404.201807001.
目的
2
探讨线粒体转位蛋白TSPO(translocator protein,TSPO)对肾脏血管紧张素Ⅱ1型受体表达及功能的影响,为高血压的防治提供新的思路。
方法
2
14周龄雄性正常血压大鼠(Wistar-Kyoto,WKY;体质量250~280 g)4只、雄性原发性高血压大鼠(spontaneously hypertensive rats,SHR;体质量250~280 g)16只,检测WKY和SHR肾脏TSPO蛋白表达水平,TSPO肾脏分布及细胞内定位。12只SHR随机分成TSPO抑制组和对照组(
n
=6),TSPO抑制组每日腹腔注射Ro5-4864(TSPO抑制剂) 0.5 mg/kg,对照组注射等量生理盐水。采用无创鼠尾测压仪测血压;代谢笼收集24 h尿量;肾上腺动脉灌注血管紧张素1型受体拮抗剂(坎地沙坦)并检测AT
1
R功能及肾脏AT
1
R蛋白表达水平。采用Ro5-4864浓度和时间梯度处理肾脏近曲小管上皮细胞(renal proximal tubule,RPT),检测AT
1
R蛋白表达水平。
结果
2
TSPO定位于线粒体;与WKY比较,SHR肾脏皮质特别是近曲小管TSPO表达明显增加。TSPO抑制组24 h尿量[(21.7±4.5)
vs
.(13.5±3.5)mL/kg
]
及尿钠排泄率[(1.5±0.3)
vs
.(1.0±0.2)mmol/kg
]
均高于对照组(
P
<0.05)。肾上腺动脉灌注坎地沙坦后,TSPO抑制组尿流速[(5.9±2.0)
vs
.(13.3±2.5)μL/min
]
及尿钠排泄率[(0.6±0.2)
vs
.(1.6±0.6)mmol/min
]
均明显低于对照组(
P
<0.05)。TSPO抑制组肾脏AT
1
R蛋白的表达显著低于对照组(
P
<0.05)。PRT细胞AT
1
R蛋白表达与Ro5-4864呈浓度及时间依赖性。
结论
2
TSPO可能通过促进肾脏AT
1
R表达及功能增强,引起水钠潴留而促进SHR血压升高。
Objective
2
To investigate the role of mitochondrial translocator protein (TSPO) in regulating the expression and function of renal angiotensin Ⅱ type 1 receptor (AT1R) in hypertensive rats and provide evidence for devising new strategies for the prevention and treatment of hypertension.
Methods
2
Four male Wistar-Kyoto (WKY) rats (14 weeks old
weight 250-280 g)
and 4 age-matched male spontaneously hypertensive rats (SHR
weight 250-280 g) were examined for the expression
renal distribution and intracellular localization of TSPO. Another 12 SHR were randomly divided into TSPO inhibition group (
n
=6) and control group (
n
=6) for daily intraperitoneal injection of Ro5-4864 (a TSPO inhibitor) at 0.5 mg/kg and an equal volume of normal saline
respectively. Blood pressure of the rats was monitored with non-invasive tail cuff blood pressure equipment
and the volume of 24-h urine was collected using metabolic cages. The changes in the function and renal expression of AT1R were detected using Western blotting after adrenal artery infusion of candesartan
an AT1R antagonist. The changes in the expression of AT1R in response to treatments with temporal and concentration gradients of Ro5-4864 were also detected in the renal proximal tubule (RPT) cells using Western blotting.
Results
2
TSPO expression was located in the mitochondria. Compared with WKY rats
SHR exhibited significantly increased expression of TSPO in the renal cortex
especially in the proximal convoluted tubules (
P
<
0.05). Compared with the control SHR
the Ro5-4864-treated SHR had significantly increased 24-h urine volume (21.7±4.5
vs
13.5±3.5 mL/kg) and urinary sodium excretion (1.5±0.3
vs
1.0±0.2 mmol/kg) (
P
<
0.05).
In Ro5-4864-treated SHR
adrenal artery infusion of candesartan caused obvious reductions in urine flow rate (5.9±2.0
vs
13.3±2.5 μL/min) and urinary sodium excretion rate (0.6±0.2
vs
1.6±0.6 mmol/min) with also significantly decreased renal expression of AT1R as compared with the control SHR (
P
<
0.05). In PRT cells
Ro5-4864 treatment reduced the expression of AT1R protein in
a
concentration-and time-dependent manner.
Conclusion
2
TSPO enhances the renal expression and function of AT1R
which causes sodium and water retention and leads to increased blood pressure in SHR.
lu J, lu Y, wang X, et al . Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)[J ] . Lancet, 2017, 390(10112): 2549-2558. DOI: 10.1016/S0140-6736(17)32478-9.
TAMURA K, WAKUI H, AZUSHIMA K, et al . Angiotensin Ⅱ type 1 receptor binding molecule ATRAP as a possible modulator of renal sodium handling and blood pressure in pathophysiology[J ] . Curr Med Chem, 2015, 22(28): 3210-3216. DOI: 10.2174/0929867322666150821095036.
SALEEM M, PiOKKUNURI I, ASGHAR M. Superoxide increases angiotensin Ⅱ AT1 receptor function in human kidney-2 cells[J]. FEBS Open Bio, 2016, 6(12): 1273-1284. DOI: 10.1002/2211-5463.
TANG G, ZHANG C, JU Z, et al . The mitochondrial membrane protein FgLetm1 regulates mitochondrial integrity, production of endogenous reactive oxygen species and mycotoxin biosynthesis in Fusarium graminearum: function of Fg Letm 1 in Fusarium graminearum[J ] . Mol Plant Pathol, 2018, 19(7): 1595-1611. DOI: 10.1111/mpp.12633.
PAN J, ZhANG J, ZhANG X, et al . Role of microRNA-29b in angiotensin Ⅱ-induced epithelial-mesenchymal transition in renal tubular epithelial cells[J ] . Int J Mol Med, 2014, 34(5): 1381-1387. DOI: 10.3892/ijmm.2014.1935.
BRIBES E, CASELLAS P, VIDAL H, et al . Peripheral benzodiazepine receptor mapping in rat kidney. Effects of angiotensin Ⅱ-inducedhypertension[J ] . J Am Soc Nephrol, 2002, 13(1): 1-9.
DRUGAN R C. Peripheralbenzodiazepine receptors: molecular pharmacology to possible physiological significance in stress-induced hypertension[J]. Clin Neuropharmacol, 1996, 19(6): 475-496.
彭晓玉, 罗浩, 王新全, 等.孕期炎症刺激对子代大鼠肾脏血管紧张素Ⅱ1型受体表达及功能的影响[J].第三军医大学学报, 2016, 38(16): 1815-1819. DOI: 10.16016/j.1000-5404.201512082.
PENG X Y, LUO H, WANG X Q, et al . Effect of LPS exposure during pregnancy on expression and function of renal angiotensin Ⅱ type 1 receptor in adult rat offsprings[J ] . J Third Mil Med Univ, 2016, 38(16): 1815-1819. DOI: 10.16016/j.1000-5404.201512082.
AllISON S J. Hypertension: IL-1 receptor-induced sodium reabsorption in hypertension[J]. Nat Rev Nephrol, 2016, 12(3): 126. DOI: 10.1038/nrneph.2016.1.
WANG X, LUO H, CHEN C, et al . Prenatal lipopolysaccharide exposure results in dysfunction of the renal dopamine D1 receptor in offspring[J ] . Free Radic Biol Med, 2014, 76: 242-250. DOI: 10.1016/j.freeradbiomed.2014.08.010.
CHIEN S J, LIN K M, KUO H C, et al . Two different approaches to restore renal nitric oxide and prevent hypertension in young spontaneously hypertensive rats: l-citrulline and nitrate[J ] . Transl Res, 2014, 163(1): 43-52. DOI: 10.1016/j.trsl.2013.09.008.
SARKAR O, LI Y, ANAND-SRIVASTAVA M B. Nitric oxide attenuates overexpression of Giα proteins in vascular smooth muscle cells from SHR: Role of ROS and ROS-mediated signaling[J]. PLoS One, 2017, 12(7): e0179301. DOI: 10.1371/journal.pone.0179301.eCollection 2017.
KORNFELD O S, HWANG S, DISATNIK M H, et al . Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases[J ] . Circ Res, 2015, 116(11): 1783-1799. DOI: 10.1161/CIRCRESAHA.116.305432.
GATLIFF J, EAST D, CROSBY J, et al . TSPO interacts with VDAC1 and triggers a ROS-mediated inhibition of mitochondrial quality control[J ] . Autophgy, 2014, 10(12): 2279-2296. DOI: 10.4161/15548627.2014.991665.
LUO H, WANG X, WANG J, et al . Chronic NF-κB blockade improves renal angiotensin Ⅱ type 1 receptor functions and reduces blood pressure in Zucker diabetic rats[J ] . Cardiovasc Diabetol. 2015, 14: 76. DOI: 10.1186/s12933-015-0239-7.
JAVKHEDKAR A A, BANDAY A A. Antioxidant resveratrol restores renal sodium transport regulation in SHR[J]. Physiol Rep, 2015, 3(11). pii: e12618. DOI: 10.14814/phy2.12618.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621